Robert Langreth
Senior healthcare reporter at Bloomberg News covering pharmaceutical industry trends, drug pricing, and medical policy with investigative reporting on cancer therapies and regulatory issues.
Best podcasts with Robert Langreth
Ranked by the Snipd community
11 snips
Oct 30, 2025 • 19min
Chipotle Falls Most Since 2012, Signals Trouble for Fast-Casual
Michael Halen, a Senior Restaurant Analyst, discusses the recent decline of Chipotle's stock and its implications for the fast-casual dining sector. Geetha Ranganathan shares insights on Comcast's ongoing subscriber losses and the difficulties facing its broadband services. Robert Langreth reveals Novo Nordisk's bold bid for MetSera, challenging Pfizer's strategic plans, while exploring MetSera's attractive drug potential against existing options. The conversation combines trends in dining, media, and pharmaceuticals, highlighting shifting market dynamics.
6 snips
Dec 17, 2025 • 20min
Many Cancer Drugs Don’t Extend Life
Robert Langreth, a senior healthcare reporter at Bloomberg News with a focus on the pharmaceutical industry, dives into the complexities of the $200 billion cancer treatment market. He reveals that fewer than half of cancer drugs truly extend patient lives, despite high costs and painful side effects. Langreth discusses the pitfalls of relying on progression-free survival, the economic incentives driving the industry, and the need for patients to prioritize treatments that promise real survival benefits over questionable profits.
